Royalty Transparency Act
- Bill Number
- H.R. 1863
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Government Operations and Politics
- Status
- Introduced
- Latest Action
- 2025-03-05: Referred to the Committee on Oversight and Government Reform, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Last Updated
- 2025-12-05T21:31:59Z
AI-Generated Summary
Purpose
The Royalty Transparency Act (H.R. 1863) aims to increase transparency in the financial disclosures of certain executive branch employees and advisory committee members by requiring them to report royalties earned from inventions developed during their government work. It seeks to prevent potential conflicts of interest, particularly in public health and science-related roles, while overriding some existing confidentiality protections for such income.
Key Provisions
- Expanded Filing Requirements: Amends Section 13103 of Title 5, U.S. Code, to require financial disclosure reports from members of specific advisory committees focused on public health, biosecurity, vaccines, science, and technology (e.g., National Science Advisory Board for Biosecurity, Advisory Committee on Immunization Practices, and others). The Government Accountability Office (GAO) must annually identify and list additional committees that provide implemented public health recommendations.
- Royalty Reporting: Under amended Section 13104 of Title 5, U.S. Code, executive branch employees (including special government employees) and qualifying advisory members must disclose the source and value of royalties from government-related inventions, including those under the Federal Technology Transfer Act of 1986. This applies to the filer, their spouse, and dependent children.
- Waiver Notifications: Amends Sections 13103 and 208 of Titles 5 and 18, U.S. Code, to require supervising ethics offices to notify specific congressional committees (e.g., Oversight and Government Reform, Energy and Commerce) of any waivers from disclosure rules, including detailed justifications.
- Public Access and Review: Updates Section 13107 of Title 5, U.S. Code, to mandate public publication of these reports on agency websites, overriding prior confidentiality under the Stevenson-Wydler Technology Innovation Act and Patent Act. Agencies must provide unredacted copies (with limited personal info redacted, like Social Security numbers) to Members of Congress within 30 days of request.
- Confidential Filers: Amends Section 13109 of Title 5, U.S. Code, to require confidential financial disclosure filers to report royalties similarly. Agencies must submit annual reports to congressional committees on confidential filings, including numbers of filers and special employees. For those reporting royalties, agencies must publicly list names, sources, and values annually.
- Conflict of Interest in Acquisitions: Directs the Federal Acquisition Regulatory Council and Office of Management and Budget to update regulations for reviewing royalties paid to contractors or grantees in conflict checks. Agencies must annually report to Congress on identified conflicts and mitigation steps.
- Sunset and Rule of Construction: The broad inclusion of advisory committees sunsets after 5 years, limiting it to successors of listed ones. The Act does not restrict advisory committees' core functions.
- Severability: If any part is ruled unconstitutional, the rest remains in effect.
Significant Changes to Existing Law
- Overrides Confidentiality: Explicitly supersedes Section 12(c) of the Stevenson-Wydler Technology Innovation Act (15 U.S.C. 3710a(c)) and Section 209 of Title 35, U.S. Code (Patent Act), which previously protected royalty details from public disclosure for government inventors.
- Broadens Scope of Filers: Adds specific advisory committee members to mandatory filers under Title 5 ethics laws, with GAO's role in ongoing determinations—a new process not previously required.
- Enhances Oversight: Introduces mandatory congressional notifications for waivers and annual agency reports on disclosures and conflicts, which were not standard before. Public website publication and expedited congressional access to reports replace more limited inspection rules.
- Acquisition Regulations: Newly mandates royalty reviews in federal contracting conflict checks, expanding beyond current financial interest disclosures.
Potential Impacts
- Government Agencies: Increased administrative workload for ethics offices, GAO, and agencies (e.g., HHS, DOD) in processing, publishing, and reporting disclosures; may strain resources for annual reviews and notifications, but promotes accountability.
- Citizens: Greater public access to information on government employees' royalty income could build trust by revealing potential biases in health and science advice, though it raises privacy concerns for individuals.
- Executive Branch Employees and Advisors: Must disclose personal financial details, potentially deterring conflicts but exposing them to public scrutiny; the 5-year sunset provides temporary expansion.
- International Relations: Minimal direct impact, though transparency in U.S. science advisory roles could indirectly affect global health collaborations by highlighting any financial influences.
Main Stakeholders Affected
- Executive Branch Employees: Particularly scientists, inventors, and special government employees in health, biosecurity, and technology fields who receive royalties from government-supported inventions.
- Advisory Committee Members: Individuals on listed public health and science committees (e.g., vaccine advisors, Defense Science Board), including their spouses and dependent children.
- Government Agencies: Ethics offices, acquisition teams, and oversight bodies like GAO; intelligence community agencies face additional reporting to intelligence committees.
- Congressional Committees: Oversight, Judiciary, Homeland Security, Commerce, Energy, and Intelligence committees gain enhanced access and reporting for monitoring ethics.
- Contractors and Grantees: Federal award recipients subject to new royalty conflict reviews in bidding processes.
- Public and Taxpayers: Benefit from transparency but not directly burdened.
Notable Legal, Constitutional, or Political Implications
- Legal: Strengthens ethics enforcement under Title 5 by mandating disclosures and public access, potentially reducing litigation over conflicts via proactive reporting; the severability clause protects the Act's core if challenged.
- Constitutional: Balances First Amendment transparency interests against privacy rights (e.g., Fourth Amendment concerns via redactions for personal data); could face challenges if seen as overreach into advisory independence, though the rule of construction preserves committee functions.
- Political: Promotes bipartisan oversight of government innovation incentives, addressing concerns about "revolving door" influences in public health policy (e.g., post-COVID vaccine scrutiny); may politically pressure agencies to mitigate conflicts, fostering public debate on inventor rights versus accountability without altering invention laws.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Rep. Griffith, H. Morgan [R-VA-9]
Cosponsors (1)
Rep. Malliotakis, Nicole [R-NY-11]
Recent Actions
- 2025-03-05: Referred to the Committee on Oversight and Government Reform, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-03-05: Referred to the Committee on Oversight and Government Reform, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-03-05: Introduced in House
- 2025-03-05: Introduced in House
Bill Versions
- Royalty Transparency Act — issued 2025-03-05 — PDF (14 pages)